Haolin Chen
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Haolin Chen has a total of 11 co-authors. Here are the top co-authors by number of shared publications:
- Gaoming Hou
Department of Urology, Second Affiliated Hospital of Shantou University Medical College, Shantou, China
2 shared publications - Qinglong Yang
Shantou University Medical College, Shantou, Guangdong, China
2 shared publications - Qingtao Yang
Department of Urology, The Second Affiliated Hospital of Shantou University Medical College
2 shared publications - Wenqiang Liao
Department of Urology, Second Affiliated Hospital of Shantou University Medical College, Shantou, China
2 shared publications - Xuxia Sui
Department of Pathogenic Biology, Shantou University Medical College, Shantou, China
2 shared publications - Zexuan Liu
Department of Urology, Second Affiliated Hospital of Shantou University Medical College, Shantou, China
2 shared publications
Latest Publications
- Open Access
- 14 March 2026
- Published by Springer Nature in Nutrition Journal
- Vol. 25 (1)
Food ultra-processing, plant-origin foods, and risk of benign prostatic hyperplasia: evidence from the UK Biobank cohort
Benign prostatic hyperplasia (BPH) frequently affects men in middle and later life; however, the potential influence of ultra-processed food (UPF) consumpt
- 14 March 2026
- Published by Springer Nature in Nutrition Journal
- Vol. 25 (1)
Open AccessFood ultra-processing, plant-origin foods, and risk of benign prostatic hyperplasia: evidence from the UK Biobank cohort
Benign prostatic hyperplasia (BPH) frequently affects men in middle and later life; however, the potential influence of ultra-processed food (UPF) consumpt
- Open Access
- 1 January 2026
- Published by XMLink in The World Journal of Men's Health
- Vol. 44
Systemic Inflammation Is Associated with the Relationship between Benign Prostatic Hyperplasia and Rheumatoid Arthritis
Benign prostatic hyperplasia (BPH) and rheumatoid arthritis (RA) have both been associated with inflammatory processes; however, their association remains unclear. This study explored the prospective association between BPH and the subsequent risk of RA using data from the UK Biobank, and further evaluated whether the systemic immune-inflammation index (SII) and the neutrophil-to-lymphocyte ratio (NLR) are associated with this relationship. A total of 222,891 males without RA or prostate cancer at baseline were included. BPH was identified through self-report, hospital ICD-10 codes (N40), and primary care records. Incident RA was defined using hospital ICD-10 codes (M05 to M06). Multivariable Cox proportional hazards models were applied to assess the association between BPH and risk of incident RA. Mediation analyses were used to explore the potential role of SII and NLR in this association. Sensitivity analyses, including subgroup analyses, multiple imputation, exclusion of early RA cases, and competing risk models, were performed to test robustness. During a median follow-up of 14 years, 2,252 incident RA cases were documented. After multivariable adjustment, BPH was associated with a higher risk of RA (hazard ratio=1.19, 95% confidence interval: 1.03 to 1.37). The association remained consistent across sensitivity analyses. Mediation analyses suggested that SII and NLR may partly account for the observed association between BPH and RA (4.28% and 7.25%, respectively). BPH was associated with an increased risk of RA, and systemic inflammatory markers were also associated with this relationship.
- 1 January 2026
- Published by XMLink in The World Journal of Men's Health
- Vol. 44
Open AccessSystemic Inflammation Is Associated with the Relationship between Benign Prostatic Hyperplasia and Rheumatoid Arthritis
Benign prostatic hyperplasia (BPH) and rheumatoid arthritis (RA) have both been associated with inflammatory processes; however, their association remains unclear. This study explored the prospective association between BPH and the subsequent risk of RA using data from the UK Biobank, and further evaluated whether the systemic immune-inflammation index (SII) and the neutrophil-to-lymphocyte ratio (NLR) are associated with this relationship. A total of 222,891 males without RA or prostate cancer at baseline were included. BPH was identified through self-report, hospital ICD-10 codes (N40), and primary care records. Incident RA was defined using hospital ICD-10 codes (M05 to M06). Multivariable Cox proportional hazards models were applied to assess the association between BPH and risk of incident RA. Mediation analyses were used to explore the potential role of SII and NLR in this association. Sensitivity analyses, including subgroup analyses, multiple imputation, exclusion of early RA cases, and competing risk models, were performed to test robustness. During a median follow-up of 14 years, 2,252 incident RA cases were documented. After multivariable adjustment, BPH was associated with a higher risk of RA (hazard ratio=1.19, 95% confidence interval: 1.03 to 1.37). The association remained consistent across sensitivity analyses. Mediation analyses suggested that SII and NLR may partly account for the observed association between BPH and RA (4.28% and 7.25%, respectively). BPH was associated with an increased risk of RA, and systemic inflammatory markers were also associated with this relationship.